Rosetta Genomics to Raise $6.6 Million in Registered Direct Offering – msnbc.com
solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Rosetta GenomicsRosetta develops and commercializes a full range of microRNA-based molecular diagnostics.
Subscribe to LegalLaw247.Com Newsletter